IL139385A - Labelled glutamine and lysine analogues, metal complexes thereof, and uses thereof for diagnosis - Google Patents
Labelled glutamine and lysine analogues, metal complexes thereof, and uses thereof for diagnosisInfo
- Publication number
- IL139385A IL139385A IL13938599A IL13938599A IL139385A IL 139385 A IL139385 A IL 139385A IL 13938599 A IL13938599 A IL 13938599A IL 13938599 A IL13938599 A IL 13938599A IL 139385 A IL139385 A IL 139385A
- Authority
- IL
- Israel
- Prior art keywords
- diagnosis
- metal complexes
- labelled
- glutamine
- lysine analogues
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/14—Peptides, e.g. proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Radiology & Medical Imaging (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98303872 | 1998-05-15 | ||
PCT/GB1999/001550 WO1999060018A1 (en) | 1998-05-15 | 1999-05-14 | Labelled glutamine and lysine analogues |
Publications (2)
Publication Number | Publication Date |
---|---|
IL139385A0 IL139385A0 (en) | 2001-11-25 |
IL139385A true IL139385A (en) | 2005-09-25 |
Family
ID=8234827
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13938599A IL139385A (en) | 1998-05-15 | 1999-05-14 | Labelled glutamine and lysine analogues, metal complexes thereof, and uses thereof for diagnosis |
Country Status (17)
Country | Link |
---|---|
US (2) | US7049289B1 (ru) |
EP (1) | EP1077998B1 (ru) |
JP (2) | JP4199420B2 (ru) |
KR (1) | KR100660509B1 (ru) |
CN (2) | CN101407543A (ru) |
AT (1) | ATE384075T1 (ru) |
AU (1) | AU762736B2 (ru) |
BR (1) | BR9910468A (ru) |
CA (1) | CA2332277A1 (ru) |
DE (1) | DE69937996T2 (ru) |
ES (1) | ES2299245T3 (ru) |
HU (1) | HUP0102154A3 (ru) |
IL (1) | IL139385A (ru) |
NO (1) | NO20005751L (ru) |
RU (1) | RU2205186C2 (ru) |
WO (1) | WO1999060018A1 (ru) |
ZA (1) | ZA200006313B (ru) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2433657A1 (en) * | 2001-01-05 | 2002-07-11 | Duke University | Contrast enhancement agent for magnetic resonance imaging |
GB0116815D0 (en) * | 2001-07-10 | 2001-08-29 | Nycomed Amersham Plc | Improved chelator conjugates |
RU2303042C2 (ru) * | 2001-07-10 | 2007-07-20 | Джи-И Хелткер АС | Соединения на основе пептидов для направленной доставки к рецепторам интегринов |
GB0223249D0 (en) * | 2002-10-08 | 2002-11-13 | Amersham Plc | Improved imaging agents |
GB0224799D0 (en) * | 2002-10-25 | 2002-12-04 | Amersham Plc | Improved complex compositions |
US20070184537A1 (en) * | 2003-06-03 | 2007-08-09 | Paul Scherrer Institut | Method for the linkage of bifunctional chelating agents and (radioactive) transition metal complexes to proteins and peptides |
GB0515974D0 (en) * | 2005-08-03 | 2005-09-07 | Ge Healthcare Ltd | Compounds and imaging methods |
KR20080071146A (ko) | 2005-11-29 | 2008-08-01 | 니혼 메디피직스 가부시키가이샤 | 방사성 할로겐 표식 유기 화합물의 전구체 화합물 |
WO2008060368A2 (en) * | 2006-10-02 | 2008-05-22 | Duke University | Transglutaminase-binding peptides and methods of use |
US20130195756A1 (en) * | 2012-01-31 | 2013-08-01 | General Electric Company | 99mTc IMAGING AGENTS AND METHODS OF USE |
EP3027228A4 (en) | 2013-08-01 | 2017-06-07 | Rochester Institute of Technology | Modular imaging agents containing amino acids and peptides |
GB201610176D0 (en) * | 2016-06-10 | 2016-07-27 | Edinburgh Molecular Imaging Ltd | Imaging agents and methods of use |
EP3538093B1 (en) * | 2016-11-09 | 2023-10-25 | Qiagen Sciences, LLC | Photoprotective mixtures as imaging reagents in sequencing-by-synthesis |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59186947A (ja) * | 1983-03-09 | 1984-10-23 | Kowa Co | 新規ペプチド |
WO1989000051A1 (en) * | 1987-07-07 | 1989-01-12 | Cytrx Biopool Ltd. | Fibrin-binding compound and method |
US5270030A (en) * | 1988-12-29 | 1993-12-14 | Bio-Technology General Corp. | Fibrin binding domain polypeptide and method of producing |
ATE197767T1 (de) * | 1992-01-03 | 2000-12-15 | Rhomed Inc | Pharmazeutische anwendungen auf der basis von peptid-metall-ionen |
US5608110A (en) * | 1993-06-15 | 1997-03-04 | Bracco International B.V. | Heteroatom-bearing ligands and metal complexes thereof |
DE69830057T2 (de) * | 1997-01-21 | 2006-06-29 | Ge Healthcare Ltd., Little Chalfont | MARKIERTE FAKTOR XIIIa SUBSTRATE |
-
1999
- 1999-05-14 AT AT99922325T patent/ATE384075T1/de not_active IP Right Cessation
- 1999-05-14 KR KR1020007012755A patent/KR100660509B1/ko not_active IP Right Cessation
- 1999-05-14 IL IL13938599A patent/IL139385A/xx not_active IP Right Cessation
- 1999-05-14 HU HU0102154A patent/HUP0102154A3/hu unknown
- 1999-05-14 BR BR9910468-7A patent/BR9910468A/pt not_active IP Right Cessation
- 1999-05-14 CN CNA2008101666071A patent/CN101407543A/zh active Pending
- 1999-05-14 CA CA002332277A patent/CA2332277A1/en not_active Abandoned
- 1999-05-14 JP JP2000549636A patent/JP4199420B2/ja not_active Expired - Fee Related
- 1999-05-14 CN CN99808609A patent/CN1309661A/zh active Pending
- 1999-05-14 WO PCT/GB1999/001550 patent/WO1999060018A1/en not_active Application Discontinuation
- 1999-05-14 EP EP99922325A patent/EP1077998B1/en not_active Expired - Lifetime
- 1999-05-14 ES ES99922325T patent/ES2299245T3/es not_active Expired - Lifetime
- 1999-05-14 DE DE69937996T patent/DE69937996T2/de not_active Expired - Lifetime
- 1999-05-14 US US09/674,616 patent/US7049289B1/en not_active Expired - Fee Related
- 1999-05-14 RU RU2000131699/04A patent/RU2205186C2/ru not_active IP Right Cessation
- 1999-05-14 AU AU39428/99A patent/AU762736B2/en not_active Ceased
-
2000
- 2000-11-03 ZA ZA200006313A patent/ZA200006313B/en unknown
- 2000-11-14 NO NO20005751A patent/NO20005751L/no unknown
-
2005
- 2005-11-02 JP JP2005319889A patent/JP2006137751A/ja active Pending
-
2006
- 2006-04-24 US US11/410,177 patent/US20060292075A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US7049289B1 (en) | 2006-05-23 |
EP1077998B1 (en) | 2008-01-16 |
HUP0102154A3 (en) | 2009-01-28 |
ES2299245T3 (es) | 2008-05-16 |
CA2332277A1 (en) | 1999-11-25 |
ZA200006313B (en) | 2002-07-17 |
AU762736B2 (en) | 2003-07-03 |
NO20005751L (no) | 2001-01-08 |
WO1999060018A1 (en) | 1999-11-25 |
CN101407543A (zh) | 2009-04-15 |
DE69937996D1 (de) | 2008-03-06 |
JP4199420B2 (ja) | 2008-12-17 |
AU3942899A (en) | 1999-12-06 |
US20060292075A1 (en) | 2006-12-28 |
EP1077998A1 (en) | 2001-02-28 |
ATE384075T1 (de) | 2008-02-15 |
DE69937996T2 (de) | 2009-01-02 |
CN1309661A (zh) | 2001-08-22 |
KR20010043608A (ko) | 2001-05-25 |
IL139385A0 (en) | 2001-11-25 |
HUP0102154A2 (hu) | 2001-09-28 |
NO20005751D0 (no) | 2000-11-14 |
RU2205186C2 (ru) | 2003-05-27 |
BR9910468A (pt) | 2001-01-09 |
JP2002515510A (ja) | 2002-05-28 |
JP2006137751A (ja) | 2006-06-01 |
KR100660509B1 (ko) | 2006-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL139385A (en) | Labelled glutamine and lysine analogues, metal complexes thereof, and uses thereof for diagnosis | |
HK1003597A1 (en) | Dual action inhibitors | |
HU9503174D0 (en) | 2-pyridylmethylenepolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents | |
PL345550A1 (en) | Pharmaceutical compositions comprising 2-quinolones | |
NO960724L (no) | Middel for transdermal applisering inneholdende gestodenestere | |
PT86224A (de) | Verbesserte metallhaltige pharmazeutika | |
ATE80571T1 (de) | Pulvermischungen auf eisenbasis. | |
EP0723602A4 (ru) | ||
MX173582B (es) | Espesante de arcilla para emplear en sistemas basados en agua y compuestos de union que contienen esas composiciones | |
BG103995A (en) | Reverse hydroxamate inhibitors of matrix metalloprreverse hydroxamate inhibitors of matrix metallprooteinases teinases | |
SG168401A1 (en) | Catalyst and use thereof | |
NZ334854A (en) | Foliar fertilisers including trace element compounds | |
GR3032287T3 (en) | Sprout inhibitor for potatoes. | |
TW349000B (en) | Fungicidal two-component composition based on R-metalaxyl and usage thereof | |
GB2411656B (en) | Ester slip agents | |
SE7910541L (sv) | Ferritisk fe-mn-legering for kryogena applikationer | |
HU9601031D0 (en) | Ibuprofen and flurbiprofen as anti-pruritic agents | |
DE59808546D1 (de) | Verwendung von fettsäureniedrigalkylestern in abbeizmitteln | |
ES2153425T3 (es) | Sulfato de tris(isonitrilo)cobre(i) para preparar complejos de radio nuclidos. | |
CA2030126A1 (en) | Process for the chemical conversion of metallic substrates, conversion bath adapted to be used in the same process and concentrate adapted for the preparation of the bath | |
GB9714997D0 (en) | Lubricant composition for metal working operations | |
WO1998031399A3 (en) | Labelled factor xiiia substrates | |
DE59807141D1 (de) | Polyrotaxane | |
EP0884378A3 (en) | Friction modifier compound and lubricating oil composition containing the same | |
RU93038588A (ru) | Сплав для получения низкокремнистого ферромарганца |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |